Fresenius Medical Care AG engages in the provision of products and services for individuals with renal diseases. The company is headquartered in Bad Homburg Vor Der Hohe, Hessen and currently employs 109,698 full-time employees. The firm provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD) and offers other extracorporeal therapies, as well as other healthcare services. The company has two operating segments such as care delivery segment which consolidates the global health care services business and care enablement segment includes research and development (R&D), manufacturing, supply chain, and commercial operations. The company develops and manufactures health care products, which includes dialysis and non-dialysis products. Such as hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals, and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. The company owns, operates, or manages dialysis clinics sells products to other dialysis providers.
最新の財務諸表(Form-10K)によると、Fresenius Medical Care AGの総資産は$0で、純損失は$0です。
FMSの主要な財務比率は何ですか?
Fresenius Medical Care AGの流動比率は0、純利益率は0、1株当たり売上高は$0です。
Fresenius Medical Care AGの収益はセグメントまたは地域別にどのように分けられていますか?
Fresenius Medical Care AG の最大収益セグメントは Care Delivery で、最新の利益発表における収益は 13,238,321,000 です。地域別に見ると、United States が Fresenius Medical Care AG の主要市場であり、収益は 14,180,803,000 です。
Fresenius Medical Care AGは収益を上げていますか?
いいえ、最新の財務諸表によると、Fresenius Medical Care AGの純損失は$0です。